Evolution of resistance to anti-cancer therapy during general dosing schedules
From MaRDI portal
Publication:1715304
DOI10.1016/J.JTBI.2009.11.022zbMath1406.92294OpenAlexW2020299413WikidataQ42909218 ScholiaQ42909218MaRDI QIDQ1715304
Publication date: 4 February 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2009.11.022
Related Items (11)
A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions ⋮ Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases ⋮ On minimising tumoural growth under treatment resistance ⋮ Inferring density-dependent population dynamics mechanisms through rate disambiguation for logistic birth-death processes ⋮ Optimal control problems for differential equations applied to tumor growth: state of the art ⋮ Optimizing Chemoradiotherapy to Target Metastatic Disease and Tumor Growth ⋮ Competition delays multi-drug resistance evolution during combination therapy ⋮ Modeling continuous levels of resistance to multidrug therapy in cancer ⋮ Practically scheduling hormone therapy for prostate cancer using a mathematical model ⋮ A quasi birth-and-death model for tumor recurrence ⋮ Deterministic and Stochastic Dynamics of Chronic Myelogenous Leukaemia Stem Cells Subject to Hill-Function-Like Signaling
Cites Work
- Unnamed Item
- Unnamed Item
- Simulation of nonhomogeneous poisson processes by thinning
- Analysis of tracer particle migration in inhomogeneous turbulence
- Optimal control for a stochastic model of cancer chemotherapy
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- Stochastic modeling of drug resistance in cancer
- Stochastic simulation: Algorithms and analysis
This page was built for publication: Evolution of resistance to anti-cancer therapy during general dosing schedules
